Iovance Biotherapeutics Inc (NASDAQ:IOVA)’s traded shares stood at 0.74 million during the latest session, with the company’s beta value hitting 0.65. At the last check today, the stock’s price was $11.82, to imply an increase of 0.21% or $0.02 in intraday trading. The IOVA share’s 52-week high remains $18.33, putting it -55.08% down since that peak but still an impressive 72.84% since price per share fell to its 52-week low of $3.21. The company has a valuation of $3.30B, with an average of 9.13 million shares over the past 3 months.

Iovance Biotherapeutics Inc (NASDAQ:IOVA) trade information

After registering a 0.21% upside in the latest session, Iovance Biotherapeutics Inc (IOVA) has traded red over the past five days. The stock hit a weekly high of 13.13, jumping 0.21% in its intraday price action. The 5-day price performance for the stock is -10.35%, and -14.93% over 30 days. With these gigs, the year-to-date price performance is 45.45%.

Iovance Biotherapeutics Inc (IOVA) estimates and forecasts

Looking at statistics comparing Iovance Biotherapeutics Inc share performance against respective industry, we note that the company has outperformed competitors. Iovance Biotherapeutics Inc (IOVA) shares are 225.76% up over the last 6 months, with its year-to-date growth rate higher than industry average at 25.40% against 13.10%.

IOVA Dividends

Iovance Biotherapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Iovance Biotherapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.